28/11/2025
Real-world data reveal that long-term usage of SGLT-2 inhibitors & GLP-1 receptor agonists isn’t just about starting the therapy, it’s about staying on it.
This new study shows distinct patterns of adherence, discontinuation and intolerance over the first year, and highlights how factors like age, s*x, BMI, socio-economic status and prior health history matter for success.
Published on: 04 November 2025 Unlocking Real-World Medication Patterns in Type 2 Diabetes Management In managing type 2 diabetes, sodium-glucose co-transport